Vetrepharm ApS: Financial statements 2012
CVR: 15206802
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Vetrepharm ApS (CVR 15206802) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,030,294 and a net result of DKK 289,138. Equity in the 2012 report amounted to DKK 1,377,499. The solvency ratio was 73.8%.
- Gross Profit
- DKK 1,030,294
- Profit/Loss
- DKK 289,138
- Equity
- DKK 1,377,499
- Total Assets
- DKK 1,865,722
Official annual report
Keep an eye on Vetrepharm ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Vetrepharm ApS
Vetrepharm ApS was a Danish company of the type Anpartsselskab based in Brande, founded in 1991. The company has been dissolved on 4 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETREPHARM A/S and A/S PSE NR. 4365. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643.